Get ready to discover the eagerly anticipated third quarter financial results of Charles River Laboratories International (NYSE: CRL) on Wednesday 6th November 2024. This significant announcement is scheduled to take place before market open, giving investors and analysts a chance to gain valuable insights into the company's financial performance.
The latest projections from financial analysts on Wall Street suggest that the organization is likely to reveal an estimated $2.43 profit per share for the quarter. Additionally, the company is expected to announce revenueS of $976.01 million for the period.
When examining the earnings report from the corresponding quarter of the previous year, it is evident that the company showcased per-share income of $2.72. This numbers can be credited to the company's total revenue, which amounted to an impressive $1.03 billion during the same quarter.
Projections for the company's annual performance have been shared by Wall Street analysts, with an estimated total revenue of $3.99 billion. Furthermore, they are predicting profit of $10 per share for the full year.
CRL will host a conference call with investment community on 6th November 2024 at 09:30 AM eastern time to discuss the financial results.
Throughout Friday's trading, Charles River Laboratories International (CRL) shares fluctuated between $179.46 and $183.94, with a trading volume of 830.10 thousand shares. The stock ended the regular trading session at $180.96, showing an increase of 1.33 percent.
